Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McGRADY, G. A.
Right arrow Articles by EVATT, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGRADY, G. A.
Right arrow Articles by EVATT, B. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 126, No. 1: 25-30
Copyright © 1987 by The Johns Hopkins University School of Hygiene and Public Health

research-article

THE COURSE OF THE EPIDEMIC OF ACQUIRED IMMUNODEFICIENCY SYNDROME IN THE UNITED STATES HEMOPHILIA POPULATION1

GENE A. McGRADY 2, JANINE M. JASON and BRUCE L. EVATT

The time course of the epidemic of acquired immunodeficiency syndrome (AIDS) as it has occurred in the US hemophilia population is examined using surveillance data collected by the Centers for Disease Control (CDC). These data indicate that the epidemic course in hemophiliacs is distinguishable from that In the homosexual/bisexual and intravenous drug-using populations in at least one respect—the epidemic in the hemophilia population is characterized by a lack of consistent increase in the number of new AIDS cases in successive time intervals. This difference is interpreted as being attributable to the mechanisms by which AIDS virus is spread among hemophiliacs. In addition, the short survival following diagnosis of AIDS in hemophiliacs and the magnitude of yearly incidence rates for this group in 1984 and 1985 show the hemophilia population to have been severely affected by the epidemic.

acquired immunodeficiency syndrome; hemophilia

1 From the Division of Host Factors, Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA, 30333

2Dr. McGrady's current address: Department of Community Health and Preventive Medicine, More-house School of Medicine Atlanta, GA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
L. W. Hoyer
Hemophilia A
N. Engl. J. Med., January 6, 1994; 330(1): 38 - 47.
[Full Text]

Home page
 ANN INTERN MEDHome page
P. K. Jones and O. D. Ratnoff
The Changing Prognosis of Classic Hemophilia (Factor VIII "Deficiency")
Ann Intern Med, April 15, 1991; 114(8): 641 - 648.
[Abstract] [PDF]

Home page
 JAMAHome page
T. Creagh-Kirk, P. Doi, E. Andrews, S. Nusinoff-Lehrman, H. Tilson, D. Hoth, and D. W. Barry
Survival Experience Among Patients With AIDS Receiving Zidovudine: Follow-up of Patients in a Compassionate Plea Program
JAMA, November 25, 1988; 260(20): 3009 - 3015.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.